# Exeliom Biosciences: Pharmaceuticals, Dijon, France

> Exeliom Biosciences: Exeliom Biosciences is a clinical-stage biotechnology company based in Dijon, France, founded in 2016. Based in Dijon, France.

Source: https://millionrounds.com/startup/exeliom-biosciences (Millionrounds; every figure on the page links to its filing or article)

France · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Exeliom Biosciences

Exeliom Biosciences is a clinical-stage biotechnology company based in Dijon, France, founded in 2016.

Funding reported Last round: Series A

Pharmaceuticals Dijon, France

Company summary

- **Founded:** 2016 10 years old
- **Team:** 9 1 to 10 people
- **Funding reported:** 22.3M as listed, currency not stated
- **Last round:** Series A Jun 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Exeliom Biosciences has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Exeliom Biosciences

Exeliom Biosciences is a clinical-stage biotechnology company based in Dijon, France, founded in 2016.

The company focuses on developing next-generation immunotherapies for immuno-oncology and immuno-inflammation by utilizing microbiome-associated innate immune regulatory mechanisms. Exeliom specializes in creating live biotherapeutic products (LBPs) using single bacterial strains from the gut microbiota to modulate the immune system, with a mission to innovate treatments for inflammatory bowel diseases, cancer, and infectious diseases. The company's lead candidate, EXL01, is an oral live biotherapeutic designed to enhance immune responses by targeting the NOD2-CARD9 pathway. EXL01 is currently in clinical trials for various conditions, including Crohn’s disease, ulcerative colitis, and several types of solid tumors. Exeliom has secured significant funding to advance its clinical development and is actively seeking partnerships and investor support to further its innovative pipeline.

## What company datasets say Exeliom Biosciences raised

Funding, as reported

Reported in all **22.3M** in the source's currency

Rounds **5**

Last round **Series A**

Last round size **3.1M**

Last round date **Jun 2023**

Investors listed **10**

## Founders and team

From Exeliom Biosciences's own website: 1 founder, 2 on the team.

**Benjamin Hadida** Co-founder and Chief Executive Officer

- **Mathilde Antoine** Operations Manager
- **Pauline Ruffié** Scientific Project Manager

## The company, in detail

What they build

Known for

health care microbiome-based immunotherapy single-strain live biotherapeutic manufacturing exl01 inflammatory bowel diseases immunomodulator microbiome microbiome-based therapies microbiome in oncology nod2 pathway activation hospital & health care microbiome research gut microbiota faecalibacterium prausnitzii immune response

Built with from their website

Amazon CloudFront CloudFlare Viewport Meta Webflow Hosting CloudFlare CDN Bunny Google Font API Microsoft Exchange gandi.net Microsoft 365 Apps & Services

+8 more

Mobile Friendly Embedly Open Graph jQuery Cloudflare DNS HTTP/3 Vimeo Amazon AWS

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 541714, 325414, SIC 2834, 8731
- **Region:** Bourgogne-Franche-Comte
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/exeliom)

## Pharmaceuticals in France

Startups like it

- [**Unither Pharmaceuticals** Paris · founded 1993](https://millionrounds.com/startup/unither-pharmaceuticals)
- [**Biose Industrie** Aurillac · founded 1951](https://millionrounds.com/startup/biose-industrie)
- [**Veracyte Biopharma Services** Marseille · founded 2015](https://millionrounds.com/startup/veracyte-biopharma-services)
- [**Pierre Fabre Laboratories** Toulouse · founded 1962](https://millionrounds.com/startup/pierre-fabre-laboratories)
- [**Futura Gaïa** Rodilhan · founded 2019](https://millionrounds.com/startup/futura-ga-a)
- [**BIODOL THERAPEUTICS** Montarnaud · founded 2015](https://millionrounds.com/startup/biodol-therapeutics)
- [**Tamrisa** Paris · founded 2024](https://millionrounds.com/startup/tamrisa)
- [**BIOPHTA** Paris · founded 2020](https://millionrounds.com/startup/biophta)

## Is this your company?

Add your raise, your deck and your story, and put Exeliom Biosciences in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)